JF
HAE icon

Jump Financial’s Haemonetics HAE Stock Holding History

Jump Financial’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,973
Closed -$1.27M – 2071
2025
Q3 		$1.27M Buy
+25,973
New +$1.61M 0.02% 905
2024
Q1 		– Sell
-12,066
Closed -$1.03M – 2048
2023
Q4 		$1.03M Buy
+12,066
New +$1.04M 0.03% 709
2023
Q3 		– Sell
-8,778
Closed -$747K – 2001
2023
Q2 		$747K Buy
8,778
+5,578
+174% +$472K 0.03% 830
2023
Q1 		$265K Buy
+3,200
New +$259K 0.01% 1173
2021
Q1 		– Sell
-2,395
Closed -$284K – 1076
2020
Q4 		$284K Buy
+2,395
New +$258K 0.05% 619

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jump Financial's HAE Position: Q4 2025 in Review

Jump Financial sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 25,973 shares — an estimated $1.27M sold.

Jump Financial first reported a position in HAE in Q4 2020 and held it in 5 quarters. The position peaked at $1.27M in Q3 2025. 328 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • Jump Financial reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
  • Jump Financial sold 25,973 Haemonetics shares in Q4 2025, an estimated $1.27M.
  • Jump Financial first reported a position in Haemonetics in Q4 2020 and held it in 5 quarters.
  • Jump Financial's Haemonetics position peaked at $1.27M in Q3 2025.
  • 328 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on Jump Financial's 13F filing for Q4 2025, filed 17 Feb 2026.